Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Heart. 2010 Aug;96(16):1297-302. doi: 10.1136/hrt.2010.194878.
The prognostic impact of reduced glomerular filtration rate (GFR) in chronic heart failure (CHF) is increasingly recognised, but little is known about tubular damage in these patients.
To investigate the prevalence of tubular damage, and its association with GFR, and prognosis in patients with CHF.
In 90 patients with CHF, GFR and effective renal plasma flow (ERPF) were measured ([(125)I]iothalamate and [(131)I]hippuran clearances). The tubular markers neutrophil gelatinase-associated lipocalin (NGAL), N-acetyl-beta-D-glucosaminidase (NAG) and kidney injury molecule 1 (KIM-1) as well as urinary albumin excretion were determined in 24 h urine collections. Mean GFR was 78+/-26 ml/min/1.73 m(2). Urinary NGAL (175 (70-346) microg/g creatinine (gCr)), NAG (12 (6-17) U/gCr) and KIM-1 (277 (188-537) ng/gCr) levels were increased compared with 20 healthy controls (all p<0.001). Urinary NAG, but not NGAL or KIM-1 correlated with GFR (r=-0.34, p=0.001) and ERPF (r=-0.29, p=0.006). Both NAG (r=0.21, p=0.048) and KIM-1 (r=0.23, p=0.033) correlated with plasma N-terminal pro-brain natriuretic peptide levels. Both urinary KIM-1 (HR=1.15 (95% CI 1.02 to 1.30) per 100 ng/gCr increase, p=0.025) and NAG (HR=1.42 (95% CI 1.02 to 1.94) per 5 U/gCr increase, p=0.039), were associated with an increased risk of death or heart failure hospitalisations, independent of GFR.
Tubular damage, as indicated by increased urinary concentrations of NGAL, NAG and KIM-1 is common in patients with CHF and mildly reduced GFR. Both urinary KIM-1 and NAG showed prognostic information additional to GFR. These findings suggest an important role for tubular damage and tubular markers in cardiorenal interaction in heart failure.
肾小球滤过率(GFR)降低对慢性心力衰竭(CHF)的预后影响已逐渐被认识,但关于这些患者的肾小管损伤知之甚少。
研究肾小管损伤的发生率及其与 GFR 和预后的关系。
在 90 例 CHF 患者中,测定了 GFR 和有效肾血浆流量(ERPF)([125I]碘酞酸盐和[131I] hippuran 清除率)。在 24 小时尿液收集物中测定了肾小管标志物中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、N-乙酰-β-D-氨基葡萄糖苷酶(NAG)和肾损伤分子 1(KIM-1)以及尿白蛋白排泄量。平均 GFR 为 78+/-26 ml/min/1.73 m(2)。与 20 名健康对照者相比,尿 NGAL(175(70-346)μg/g 肌酐(gCr))、NAG(12(6-17)U/gCr)和 KIM-1(277(188-537)ng/gCr)水平升高(均 p<0.001)。尿 NAG 与 GFR(r=-0.34,p=0.001)和 ERPF(r=-0.29,p=0.006)相关,但 NGAL 或 KIM-1 无相关性。NAG(r=0.21,p=0.048)和 KIM-1(r=0.23,p=0.033)与血浆 N-末端脑钠肽前体水平相关。尿 KIM-1(HR=1.15(95%CI 1.02 至 1.30),每增加 100 ng/gCr,p=0.025)和 NAG(HR=1.42(95%CI 1.02 至 1.94),每增加 5 U/gCr,p=0.039)与死亡或心力衰竭住院风险增加相关,独立于 GFR。
在 GFR 轻度降低的 CHF 患者中,肾小管损伤较为常见,表现为尿中 NGAL、NAG 和 KIM-1 浓度升高。尿 KIM-1 和 NAG 均提供了 GFR 之外的预后信息。这些发现提示肾小管损伤和肾小管标志物在心力衰竭中心肾交互作用中具有重要作用。